Posters

Presenting Author

Luis Mario Rodriguez

Presentation Type

Poster

Discipline Track

Community/Public Health

Abstract Type

Research/Clinical

Abstract

Background: COVID-19 represents a significant threat to global human health. SARS-CoV-2, the etiologic viral agent, needs to be under-covered at the structural biology level to facilitate the rational design of diagnostic tests and vaccine candidates. SARS-CoV-2 Receptor Binding Domain of Spike protein (RBD-S) acts as the key to open the gate, to enter the cells during infection. Thus, it is a stronger candidate for designing effective antigens for vaccines and diagnostics. Here, we relied on the viral DNA codifying to RBD-S to use synthetic biology for optimizing the recombinant expression of this (rRBD-S) as a proof of concept of rational designs of bioprocess for vaccine candidates and immunogens to improved rapid diagnostic tests.

Methods: rRBD-S coding sequences inspired on RBD-S ectodomain from SARS-CoV-2 were designed, codon-optimized, tagged, synthesized, cloned in an expression vector (pD444-MR), and transformed into C41(DE3)pLysS E. coli strain. Expression of recombinant RBD-S was resulting in a protein purified using Ni-IMAC (Nickel Immobilized metal affinity chromatography).

Results: rRBD-S produced result in a ~30KDa protein with yields of 4.618 gr L-1. Protein was recovered from the bacterial soluble fraction without refolding process.

Conclusions: rRBD-S is an important tool for immunity diagnostics as Lateral-Flow-Devices, structural biology studies, and even as vaccine candidate for combating SARS-CoV-2. Notably considering the advantages of rational subunit vaccines for immune response against other vaccines technologies whose effectiveness in the long-term process has not been demonstrated yet.

Acknowledgements: We thank HIDALGO´s Council of Science, Technology and Innovation (CITNOVA) for the GRANT 20201122 to LMRM.

Academic/Professional Position

Other

Academic/Professional Position (Other)

PhD

Share

COinS
 

Rational design for the recombinant expression of the Receptor Binding Domain of SARS-CoV-2 Spike Glycoprotein

Background: COVID-19 represents a significant threat to global human health. SARS-CoV-2, the etiologic viral agent, needs to be under-covered at the structural biology level to facilitate the rational design of diagnostic tests and vaccine candidates. SARS-CoV-2 Receptor Binding Domain of Spike protein (RBD-S) acts as the key to open the gate, to enter the cells during infection. Thus, it is a stronger candidate for designing effective antigens for vaccines and diagnostics. Here, we relied on the viral DNA codifying to RBD-S to use synthetic biology for optimizing the recombinant expression of this (rRBD-S) as a proof of concept of rational designs of bioprocess for vaccine candidates and immunogens to improved rapid diagnostic tests.

Methods: rRBD-S coding sequences inspired on RBD-S ectodomain from SARS-CoV-2 were designed, codon-optimized, tagged, synthesized, cloned in an expression vector (pD444-MR), and transformed into C41(DE3)pLysS E. coli strain. Expression of recombinant RBD-S was resulting in a protein purified using Ni-IMAC (Nickel Immobilized metal affinity chromatography).

Results: rRBD-S produced result in a ~30KDa protein with yields of 4.618 gr L-1. Protein was recovered from the bacterial soluble fraction without refolding process.

Conclusions: rRBD-S is an important tool for immunity diagnostics as Lateral-Flow-Devices, structural biology studies, and even as vaccine candidate for combating SARS-CoV-2. Notably considering the advantages of rational subunit vaccines for immune response against other vaccines technologies whose effectiveness in the long-term process has not been demonstrated yet.

Acknowledgements: We thank HIDALGO´s Council of Science, Technology and Innovation (CITNOVA) for the GRANT 20201122 to LMRM.

blog comments powered by Disqus
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.